PA Reporter

PA Media is the national news agency of the UK and Ireland. Founded in 1868, PA’s mission lies in delivering timely fact-based news on a broad range of topics including current events, government and politics, business and technology, transport, social affairs, environment, health and wellness. PA’s reporters, photographers and videographers across the five nations focus on quality newsgathering, which is reflected in its values of always being fast, fair and accurate.

57%

The Daily's Verdict

This author has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on the author's reporting.

Bias

80%

Examples:

  • The Financial Times shows bias by reporting on the allegations of voter ID scheme bias without providing any evidence or context.

Conflicts of Interest

50%

Examples:

  • The PA Reporter may have a conflict of interest as they are part of the national news agency that is funded by various sources and may be influenced by their interests or agendas.

Contradictions

85%

Examples:

  • Both The Daily Telegraph and The Times make false claims about a blood test for Alzheimer's disease being able to detect it up to 15 years before symptoms show. This is not supported by any scientific evidence and has been debunked in previous studies.

Deceptions

30%

Examples:

  • The Daily Telegraph and The Times use deceptive practices by exaggerating the claims of a blood test for Alzheimer's disease without providing any credible evidence or citation.

Recent Articles

Early Detection of Alzheimer's with ALZpath Dx Blood Test: A Gamechanger for Early Intervention and Treatment

Early Detection of Alzheimer's with ALZpath Dx Blood Test: A Gamechanger for Early Intervention and Treatment

Broke On: Tuesday, 23 January 2024 A new blood test called ALZpath Dx can detect Alzheimer's disease up to 15 years before symptoms appear, potentially allowing for earlier intervention and treatment. The test is just as accurate as current gold-standard methods of diagnosis and has the potential to be a gamechanger for early detection and treatment of Alzheimer's.